Systemic sclerosis and occupational exposure to solvents;Sclérodermie et exposition professionnelle aux solvants organiques

Archives des Maladies Professionnelles et de l'Environnement

Volumn 67, Issue 3, 2006, Pages 488-504

  Garnier, R ^a   Bazire, A ^a   Chataigner, D ^a  

^a HÔPITAL FERNAND WIDAL   (France)

Author keywords

Occupational exposure; Solvents; Systemic sclerosis

Indexed keywords

SOLVENT;

DATA ANALYSIS; DATA BASE; DISEASE COURSE; ENVIRONMENTAL FACTOR; HUMAN; OCCUPATIONAL EXPOSURE; PUBLICATION; REVIEW; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS; WORKPLACE;

EID: 33745895010     PISSN: 17758785     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1775-8785(06)70389-7     Document Type: Article

References (84)

1. Fautrel B., Aeschliman A., Bourgeois-Droin C., Bourgeois P. : Sclérodermies. In : Kahn MF, AP Peltier, O Meyer, JC Piette, editors. Maladies et syndromes systémiques. 4ème éd. Paris: Flammarion Médecine-Sciences, 2000 : 469-521.
2. Gilliland BC. : Systemic sclerosis (scleroderrna). In : Fauci AS., E Braunwald, KJ Isselbacher, JD Wilson, JB Martin, DL Kasper, et al., editors. Harrison's principles of internal medicine. 14th ed. New-York: McGraw-Hill, 1998 : 1888-1901.
3. Mayes MD. : Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol, 1997 ; 9 : 557-561.
4. Laing T.J., Gillespie B.W., Toth M.B., Mayes M.D., Gallavan R.H. Jr., Burns C.J., Johanns JR., Cooper B.C., Keroack B.J., Wasko M.C., Lacey J.V. Jr.,Schottenfeld D. : Racial differences in scleroderma among women in Michigan. Arthritis Rheum, 1997 ; 40 : 734-742.
5. Arnett F.C., Howard R.F., Tan F., Moulds J.M., Bias W.B., Durban E., Cameron H.D., Paxton G., Hodge T.J., Weathers P.E., Reveille J.D. : Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum, 1996 ; 39 : 1362-1370.
6. Posada de la Paz M., Philen R.M., Schurz H., Hill R.H. Jr., Gimenez Ribota O., Gomez de la Camara A., Kilbourne E.M., Abaitua I. : Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome. Epidemiology, 1999 ; 10 : 130-134.
7. Tabuenca J.M. : Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet, 1981 ; 2 : 567-568.
8. Philen R.M., Posada M. : Toxic oil syndrome and eosinophiliamyalgia syndrome: May 8-10, 1991, World Health Organization meeting report. Semin Arthritis Rheum, 1993 ; 23 : 104-124.
9. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett, 2000 ; 112-113 : 421-432.
10. Yamakage A., Ishikawa H., Saito Y., Hattori A. : Occupational scleroderma-like disorder occurring in men engaged in the polymerization of epoxy resins. Dermatologica, 1980 ; 161 : 33-44.
11. Ishikawa O., Warita S., Tamura A., Miyachi Y. : Occupational scleroderma. A 17-year follow-up study. Br J Dermatol, 1995 ; 133 : 786-789.
12. Kumagai Y., Shiokawa Y., Medsger TA. Jr., Rodnan G.P. : Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum, 1984 ; 27 : 1-12.
13. Sanchez-Guerrero J., Colditz G.A., Karlson E.W., Hunter D.J., Speizer F.E., Liang M.H. : Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med, 1995 ; 332 : 1666-1670.
14. Sanchez-Guerrero J., Liang MH. : Silicone breast implants and connective tissue diseases. Bmj, 1994 ; 309 : 822-823.
15. Gabriel S.E., O'Fallon W.M., Kurland L.T., Beard C.M., Woods J.E., Melton L.J. 3rd. : Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med, 1994 ; 330 : 1697-1702.
16. Hochberg M.C., Perlmutter D.L., Medsger T.A. Jr., Nguyen K., Steen V., Weisman M.H., White B., Wigley F.M. : Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). Arthritis Rheum, 1996 ; 39 : 1125-1131.
17. Hennekens C.H., Lee I.M., Cook N.R., Hebert P.R., Karlson E.W., LaMotte F., Manson J.E., Buring J.E. : Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. Jama, 1996 ; 275 : 616-621.
18. Edworthy S.M., Martin L., Barr S.G., Birdsell D.C., Brant R.F., Fritzler M.J. : A clinical study of the relationship between silicone breast implants and connective tissue disease. J Rheumatol 1998 ; 25 : 254-260.
19. Kilaru P., Kim W., Sequeira W. : Cocaine and scleroderma: is there an association? J Rheumatol, 1991 ; 18 : 1753-1755.
20. Finch W.R., Rodnan GP., Buckingham R.B., Prince RK., Winkelstein A. : Bleomycin-induced scleroderma. J Rheumatol, 1980 ; 7 : 651-659.
21. Parks D.L., Perry H.O., Muller S.A. : Cutaneous complications of pentazocine injections. Arch Dermatol, 1971 ; 104 : 231-235.
22. Aeschlimann A., de Truchis P., Kahn M.F. : Scleroderma after therapy with appetite suppressants. Report on four cases. Scand J Rheumatol. 1990 ; 19 : 87-90.
23. Miyagawa S., Yoshioka A., Hatoko M., Okuchi T., Sakamoto K. : Systemic sclerosis-like lesions during long-term penicillamine therapy for Wilson's disease. Br J Dermatol 1987 ; 116 : 95-100.
24. Sternberg E.M., Van Woert M.H., Young S.N., Magnussen I., Baker H., Gauthier S., Osterland CK. : Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med, 1980 ; 303 : 782-787.
25. Owens G.R., Medsger T.A. : Systemic sclerosis secondary to occupational exposure. Am J Med, 1988 ; 85 : 114-116.
26. Rush P.J., Chaiton A. : Scleroderma, renal failure and death associated with exposure to urea formaldehyde foam insulation. J Rheumatol, 1986 ; 13 : 475-476.
27. Fessel W.J. : Scleroderma and welding. N Engl J Med, 1977 ; 296 : 1537.
28. Diot E., Lesire V., Guilmot J.L., Metzger M.D., Pilore R., Rogier S., Stadler M., Diot P., Lemarie E., Lasfargues G. : Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med, 2002 ; 59 : 545-549.
29. Schaeverbeke T., Halle O., Moride Y., Constans J., Pellegren J.L., Conri C., Leng B., Beylot C., Bannwarth B. : Systemic sclerosis (SSc) and prolonged exposure to toxic (abstract). Arthritis Rheum, 1995 ; 38 : S332.
30. Laing T.J., Gillespie B.W., Burns C.J., Garabrant D., Heeringa S., Alcser K. : Risk factors for scleroderma among Michigan women. Arthritis Rheum, 1995 ; 38 : S341.
31. Rodnan G.P., Benedek T.G., Medsger T.A. Jr., Cammarata R.J. : The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Ann Intern Med, 1967 ; 66 : 323-334.
32. von Ziegler V., Haufstein UF., Mehlhorn J., Münzberger H., Rennau H. : Quartzinduzierte Sklerodermie. Sklerodermie-ähnliches Syndrom oder echte progressive Sklerodermie ? Dermatol Monschr, 1986 ; 172 : 86-90.
33. Cowie R.L. : Silica-dust-exposed mine workers with scleroderma (systemic sclerosis). Chest, 1987 ; 92 : 260-262.
34. Bramwell B. : Diffuse scleroderma : itsfrequency ; its occurrence in stone-masons ; its treatment by fibrolysin-elevations of temperature due to fibrolysin injections. Edinburgh Med J, 1914 ; 12 : 387-401.
35. Erasmus LD. : Sleroderma in gold miners on the witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med, 1957 ; 3 : 209-231.
36. Reinl W. : Sklerodermie durch Trichloräthylen-Einwirkung. Zentralbl Arbeitsmed Arbeitsschutz, 1957 ; 7 : 58-60.
37. Walder B. Solvents and scleroderma. Lancet, 1965 ; 2 : 436-437.
38. Sparrow G.P., A connective tissue disorder similar to vinyl chloride disease in a patient exposed to perchlorethylene. Clin Exp Dermatol, 1977 ; 2 : 17-22.
39. Saihan E.M., Burton J.L., Heaton K.W. : A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropathy. Br J Dermatol, 1978 ; 99 : 437-440.
40. Yamakage A., Ishikawa H. : Generalized morphea-like scleroderma occurring in people exposed to organic solvents. Dermatologica, 1982 ; 165 : 186-193.
41. Flindt-Hansen H., Isager H. : Scleroderma after occupational exposure to trichlorethylene and trichlorethane. Acta Derm Venereol, 1987 ; 67 : 263-264.
42. Lockey J.E., Kelly C.R., Cannon G.W., Colby T.V., Aldrich V., Livingston G.K. : Progressive systemic sclerosis associated with exposure to trichloroethylene. J Occup Med, 1987 ; 29 : 493-496.
43. Czirjak L., Danko K., Schlammadinger J., Suranyi P., Tamasi L., Szegedi G.Y. : Progressive systemic sclerosis occurring in patients exposed to chemicals. Int J Dermatol, 1987 ; 26 : 374-378.
44. Czirjak L., Szegedi G. : Benzene exposure and systemic sclerosis. Ann Intern Med, 1987 ; 107 : 118.
45. Czirjak L., Bokk A., Csontos G., Lorincz G., Szegedi G. : Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol, 1989 ; 69 : 533-536.
46. Brasington R.D. Jr., Thorpe-Swenson A.J. : Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature. Arthritis Rheum, 1991 ; 34 : 631-633.
47. Yanez Diaz S., Moran M., Unamuno P., Armijo M. : Silica and trichloroethylene-induced progressive systemic sclerosis. Dermatology, 1992 ; 184 : 98-102.
48. Pelmear P.L., Roos J.O., Maehle W.M. : Occupationally-induced scleroderma. J Occup Med 1992 ; 34 : 20-25.
49. Czirjak L., Schlammadinger J., Szegedi G. : Systemic sclerosis and exposure to trichloroethylene. Dermatology, 1993 ; 186 : 236-237.
50. Bottomley W.W., Sheehan-Dare R.A., Hughes P., Cunliffe W.J. : A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol, 1993 ; 128 : 203-206.
51. Czirjak L., Pocs E., Szegedi G. : Localized scleroderma after exposure to organic solvents. Dermatology, 1994 ; 189 : 399-401.
52. Hinnen U., Schmid-Grendelmeier P., Müller E., Elsner P. : Lösungsmittelexposition bei Sklerodermie : disseminierte zirkumskripte Sklerodermie (Morphea) bei einem Perchlorethylen-exponierten Lackierer. Schweiz Med Wschr, 1995 ; 125 : 2433-2437.
53. Garcia-Zamalloa A.M., Ojeda E., Gonzalez-Beneitez C., Goni J., Garrido A. : Systemic sclerosis and organic solvents: early diagnosis in industry. Ann Rheum Dis, 1994 ; 53 : 618.
54. Altomonte A., Zoli A., Galossi A., Mancusa L., Mirone L., Magnavita N., Federico F., Magaro M. : Scleroderma-like disease following occupational exposure to organic solvents. Clin Rheumatol, 1996 ; 15 : 416-417.
55. Rivière-Orset G., Bertrand O., Ulrich G., Pinault A.L., Petiet G. : Sclérodermie et exposition professionnelle aux solvants. A propos de deux cas. Arch Mal Prof, 2003 ; 64 : 510-514.
56. Sumi K., Yamamoto T., Yokozeki H., Nishioka K. : Amyloid deposition associated with generalized morphea-like scleroderma. Eur J Dermatol, 2003 ; 13 : 509-511.
57. Calvani N., Silvestris F., Dammacco F. : Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Ann Ital Med Int, 2001 ; 16 : 175-178.
58. Tibon-Fisher O., Heller E,Ribak J. : [Occupational scleroderma due to organic solvent exposure] English summary. Harefuah, 1992 ; 122 : 530-532, 551.
59. Szeimies RM., Lissner A., Meurer M. : Perchlorethylen-induzierte systemische Sklerodermie. Dermatosen in Beruf und Umwelt, 1992 ; 40 : 66-69.
60. Sverdrup B. : Do workers in the manufacturing industry run an increased risk of getting scleroderma? Int J Dermatol, 1984 ; 23 : 629.
61. Silman A.J., Jones S. : What is the contribution of occupational environmental factors to the occurrence of scleroderma in men? Ann Rheum Dis, 1992 ; 51 : 1322-1324.
62. Conte C., Steen V. : An epidemiologic study of occupational exposures in systemic sclerosis (abstract). Arthritis Rheum, 1992 ; 35 : S150.
63. Lundberg I., Alfredsson L., Plato N., Sverdrup B., Klareskog L., Kleinau S. : Occupation, occupational exposure to chemicals and rheumatological disease. A register based cohort study. Scand J Rheumatol, 1994 ; 23 : 305-310.
64. Bovenzi M., Barbone F., Betta A., Tommasini M., Versini W. : Scleroderma and occupational exposure. Scand J Work Environ Health, 1995 ; 21 : 289-292.
65. Goldman J.A. Connective tissue disease in people exposed to organic solvents : systemic sclerosis (scleroderma) in dry cleaning plant and aicraft industry workers. J Clin Rheumatol, 1996 ; 2 : 185-190.
66. Zachariae H., Bjerring P., Sondergaard KH., Halkier-Sorensen L. : [Occupational systemic sclerosis in men]. Ugeshr Laeger 1997 ; 159 : 2687-2689.
67. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Knapp R.G., Hoel D.G., Dosemeci M. : Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum, 1998 ; 41 : 1111-1118.
68. Arnaud J., de Gaudemaris R., Carpentier P., Hours M., Bergeret A. : Sclérodermie et facteurs professionnels de l'environnement : étude cas-témoins en population générale. Arch Mal Prof, 2002 ; 63 : 144.
69. Czirjak L., Kumanovics G. : Exposure to solvents in female patients with scleroderma. Clin Rheumatol, 2002 ; 21 : 114-118.
70. Garabrant D.H., Lacey J.V. Jr., Laing T.J., Gillespie B.W., Mayes M.D., Cooper B.C., Schottenfeld D. : Scleroderma and solvent exposure among women. Am J Epidemiol, 2003 ; 157 : 493-500.
71. Bovenzi M., Barbone F., Pisa FE., Betta A., Romeo L., Tonello A., Biasi D., Caramaschi P. : A case-control study of occupational exposures and systemic sclerosis. Int Arch Occup Environ Health, 2004 ; 77 : 10-16.
72. Maitre A., Hours M., Bonneterre V., Arnaud J., Arslan MT., Carpentier P., Bergeret A., de Gaudemaris R. : Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol, 2004 ; 31 : 2395-2401.
73. Lacey J.V. Jr., Garabrant D.H., Laing T.J., Gillespie B.W., Mayes M.D., Cooper B.C., Schottenfeld D. : Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol 1999 ; 149 : 761-770.
74. Garabrant D.H., Dumas C. : Epidemiology of organic solvents and connective tissue disease. Arthritis Res, 2000 ; 2 : 5-15.
75. Reckner Olsson A., Skogh T., Wingren G. : Occupational determinants for rheumatoid arthritis. Scand J Work Environ Health, 2000 ; 26 : 243-249.
76. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Dosemeci M. : Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol, 1999 ; 26 : 2369-2372.
77. Bégaud B., Evreux J.C., Jouglard J., Lagier G. : Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Thérapie, 1985 ; 40 : 111-118.
78. Bradford Hill A. : The environment and disease : Association or causation ? Proc Royal Soc Med, 1965 : 295-300.
79. Stengel B., Cenee S., Limasset J.C., Protois J.C., Marcelli A., Brochard P., Hemon D. : Organic solvent exposure may increase the risk of glomerular nephropathies with chronic renal failure. Int J Epidemiol, 1995 ; 24 : 427-434.
80. Landtblom A.M. : Exposure to organic solvents and multiple sclerosis. Neurology, 1997 ; 49 : S70-74.
81. Khan M.F., Kaphalia B.S., Prabhakar B.S., Kanz M.F., Ansari G.A. : Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol, 1995 ; 134 : 155-160.
82. Griffin J.M., Blossom S.J., Jackson S.K., Gilbert K.M., Pumford N.R. : Trichloroethylene accelerates an autoimmune response by Th1 T cell activation in MRL +/+ mice. Immunopharmacology, 2000 ; 46 : 123-137.
83. Halmes N.C., McMillan D.C., Oatis J.E. Jr., Pumford N.R. : Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chem Res Toxicol, 1996 ; 9 : 451-456.
84. Cooper G.S., Miller F.W., Germolec D.R. : Occupational exposures and autoimmune diseases. Int Immunopharmacol, 2002 ; 2 : 303-313.